Cargando…
Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach
Amyotrophic lateral sclerosis (ALS) is a progressive and incurable neurodegenerative disease. Although several compounds have shown promising results in preclinical studies, their translation into clinical trials has failed. This clinical failure is likely due to the inadequacy of the animal models...
Autores principales: | Morello, Giovanna, Spampinato, Antonio Gianmaria, Conforti, Francesca Luisa, D’Agata, Velia, Cavallaro, Sebastiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359376/ https://www.ncbi.nlm.nih.gov/pubmed/28236105 http://dx.doi.org/10.1007/s12031-017-0898-9 |
Ejemplares similares
-
From Multi-Omics Approaches to Precision Medicine in Amyotrophic Lateral Sclerosis
por: Morello, Giovanna, et al.
Publicado: (2020) -
Taxonomy Meets Neurology, the Case of Amyotrophic Lateral Sclerosis
por: Morello, Giovanna, et al.
Publicado: (2018) -
Copy Number Variations in Amyotrophic Lateral Sclerosis: Piecing the Mosaic Tiles Together through a Systems Biology Approach
por: Morello, Giovanna, et al.
Publicado: (2017) -
Molecular Taxonomy of Sporadic Amyotrophic Lateral Sclerosis Using Disease-Associated Genes
por: Morello, Giovanna, et al.
Publicado: (2017) -
Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS
por: Morello, Giovanna, et al.
Publicado: (2019)